Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

543 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Calprotectin Impairs Platelet Survival in Patients With Primary Antiphospholipid Syndrome.
Hoy CK, NaveenKumar SK, Navaz SA, Sugur K, Yalavarthi S, Sarosh C, Smith T, Kmetova K, Chong E, Peters NF, Rysenga CE, Norman GL, Figueroa-Parra G, Nelson D, Girard J, Ahmed AZ, Schaefer JK, Gudjonsson JE, Kahlenberg JM, Madison JA, Knight JS, Crowson CS, Duarte-García A, Zuo Y. Hoy CK, et al. Among authors: chong e. Arthritis Rheumatol. 2024 Jun;76(6):928-935. doi: 10.1002/art.42801. Epub 2024 Mar 15. Arthritis Rheumatol. 2024. PMID: 38225923
Non-criteria antiphospholipid antibodies and calprotectin as potential biomarkers in pediatric antiphospholipid syndrome.
Sloan EE, Kmetova K, NaveenKumar SK, Kluge L, Chong E, Hoy CK, Yalavarthi S, Sarosh C, Baisch J, Walters L, Nassi L, Fuller J, Turnier JL, Pascual V, Wright TB, Madison JA, Knight JS, Zia A, Zuo Y. Sloan EE, et al. Among authors: chong e. Clin Immunol. 2024 Apr;261:109926. doi: 10.1016/j.clim.2024.109926. Epub 2024 Feb 13. Clin Immunol. 2024. PMID: 38355030
Prolonged neurologic symptoms following immune effector cell-associated neurotoxicity syndrome in patients with large B cell lymphoma treated with chimeric antigen receptor-modified T cell therapy.
Maillie L, Nasta SD, Svoboda J, Barta SK, Chong EA, Garfall AL, Gill SI, Porter DL, Schuster SJ, Catania C, Frey NV, Landsburg DJ. Maillie L, et al. Among authors: chong ea. Transplant Cell Ther. 2025 Jan 21:S2666-6367(25)00912-1. doi: 10.1016/j.jtct.2025.01.884. Online ahead of print. Transplant Cell Ther. 2025. PMID: 39848443
Exploring treatment-driven subclonal evolution of prognostic triple biomarkers: Dual gene fusions and chimeric RNA variants in novel subtypes of acute myeloid leukemia patients with KMT2A rearrangement.
Xu Y, Li SC, Xiao J, Liu Q, Cherukuri D, Liu Y, Mirshahidi S, Xu J, Chen X, Homa D, Olea J, Wu K, Kelly KR, Sun F, Huang R, Wang X, Wen Q, Zhang X, Ghiuzeli CM, Chong E, Abdel-Azim H, Reeves ME, Baylink DJ, Cao H, Zhong JF. Xu Y, et al. Among authors: chong e. Drug Resist Updat. 2025 Jan 2;79:101199. doi: 10.1016/j.drup.2024.101199. Online ahead of print. Drug Resist Updat. 2025. PMID: 39823827 Free article.
Retinal thickness predicts the risk of cognitive decline over five years.
Eppenberger LS, Li C, Wong D, Tan B, Garhöfer G, Hilal S, Chong E, Toh AQ, Venketasubramanian N, Chen CL, Schmetterer L, Chua J. Eppenberger LS, et al. Among authors: chong e. Alzheimers Res Ther. 2024 Dec 23;16(1):273. doi: 10.1186/s13195-024-01627-0. Alzheimers Res Ther. 2024. PMID: 39716304 Free PMC article.
543 results